How To Efficiently Recruit The Right Patients For Your Next DTx Study

A common trend throughout the DTx industry is the growing need for real-world clinical evidence collection in settings mimicking that of the intended use case – implying that studies for digital therapeutics should be taking place at least partly in settings where patients would be using them most often. This is particularly important for sponsors seeking regulatory submission and approval. Additionally, the participants in a study need to be an accurate representation of the patients who will likely be prescribed that digital therapy in the real world. 

The Digital Therapeutics Alliance (DTA)’s newest whitepaper, Setting the Stage for a Fit-For-Purpose DTx Evidentiary Standard, states “equitable participant selection is fundamental for enhancing the social value of DTx products and promoting their clinical effectiveness.” Furthermore, “insufficient participation from some groups within a population can result in inadequate information pertaining to the safety and effectiveness of the DTx product in important subpopulations.” In order to capture the proper data points within an applicable study setting among a representative patient population, appropriate patient recruitment strategies and execution are crucial.